par Rozencweig, Marcel
;Abele, R;Piccart-Gebhart, Martine
;Von Hoff, D D;Muggia, F
Référence Recent Results in Cancer Research, 74, page (72-77)
Publication Publié, 1980


Référence Recent Results in Cancer Research, 74, page (72-77)
Publication Publié, 1980
Article révisé par les pairs
Résumé : | N-(Phosphonoacetyl)-L-aspartate (PALA) is a synthetic antimetabolite exhibiting striking oncolytic properties against a wide variety of experimental solid tumors. The clinical dose-limiting factor is mucocutaneous toxicity which is reversible and dose-related. Delineation of the single-agent activity of PALA in human cancer must still await results of recently activated trials. |